Dupilumab Decreases Concomitant Therapy use in Adults with Atopic Dermatitis in Clinical Practice: Subgroup Analysis of Black/African American Population from RELIEVE-AD
Main Article Content
Keywords
atopic dermatitis, concomitant therapy, dupilumab
References
1. Dupixent® (dupilumab). Highlights of prescribing information. https://www.regeneron.com/downloads/dupixent_fpi.pdf. Accessed August 8, 2023.
2. Dupixent® (dupilumab). Summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/dupixent-epar-product information_en.pdf. Accessed August 8, 2023.
3. Simpson EL, et al. N Eng J Med 2016;375(24):2335-2348.
4. Simpson EL. Dermatol Ther (Heidelb) 2017;7(2):243-248.
5. Deleuran M, et al. J Am Acad Dermatol 2020;82(2):377-388.
6. Simpson EL, et al. JAMA Dermatol 2020;156(1):44-56.
7. Cork MJ, et al. Br J Dermatol 2020;182(1):85-96.
8. Paller AS, et al. J Am Acad Dermatol 2020;83(5):1282-1293.
9. Cork MJ, et al. Br J Dermatol 2021;184(5):857-870.
10. Paller AS, et al. Lancet 2022;400(10356):908-919.
11. Blauvelt A, et al. Am J Clin Dermatol 2022;23(3):365-383.
12. Strober B, et al. JAMA Dermatol 2022;158(2):142-150.
2. Dupixent® (dupilumab). Summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/dupixent-epar-product information_en.pdf. Accessed August 8, 2023.
3. Simpson EL, et al. N Eng J Med 2016;375(24):2335-2348.
4. Simpson EL. Dermatol Ther (Heidelb) 2017;7(2):243-248.
5. Deleuran M, et al. J Am Acad Dermatol 2020;82(2):377-388.
6. Simpson EL, et al. JAMA Dermatol 2020;156(1):44-56.
7. Cork MJ, et al. Br J Dermatol 2020;182(1):85-96.
8. Paller AS, et al. J Am Acad Dermatol 2020;83(5):1282-1293.
9. Cork MJ, et al. Br J Dermatol 2021;184(5):857-870.
10. Paller AS, et al. Lancet 2022;400(10356):908-919.
11. Blauvelt A, et al. Am J Clin Dermatol 2022;23(3):365-383.
12. Strober B, et al. JAMA Dermatol 2022;158(2):142-150.